Hypoglycemia-associated autonomic failure in diabetes

Action to Control Cardiovascular Risk in Diabetes Study Group ACCORD, 2008, Effects of intensive glucose lowering in type 2 diabetes, N Engl J Med, 358, 2545, 10.1056/NEJMoa0802743 Adler, 2009, Antecedent hypoglycemia impairs autonomic cardiovascular function, Implications for rigorous glycemic control. Diabetes, 58, 360 American Diabetes Association Workgroup on Hypoglycemia, 2005, Defining and reporting hypoglycemia in diabetes, Diabetes Care, 28, 1245, 10.2337/diacare.28.5.1245 Arbelaez, 2008, Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition: a mechanism for hypoglycemia-associated autonomic failure, Diabetes, 57, 470, 10.2337/db07-1329 Banarer, 2002, Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response, Diabetes, 51, 958, 10.2337/diabetes.51.4.958 Bolli, 1984, A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus, Diabetes, 33, 732, 10.2337/diab.33.8.732 Bonadonna, 2010, Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study, J Clin Endocrinol Metab, 95, 5028, 10.1210/jc.2010-1041 Cooke, 2009, Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA(1c) in insulin-treated diabetes (MITRE Study), Diabet Med, 26, 540, 10.1111/j.1464-5491.2009.02723.x Cooperberg, 2009, Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans, Diabetes Care, 32, 2275, 10.2337/dc09-0798 Cooperberg, 2010, Insulin reciprocally regulates glucagon secretion in humans, Diabetes, 59, 2936, 10.2337/db10-0728 Cranston, 1994, Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes, Lancet, 344, 283, 10.1016/S0140-6736(94)91336-6 Cryer, 2001, The prevention and correction of hypoglycemia (Ch. 35), Vol. II, 1057 Cryer, 2006, Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes, J Clin Invest, 116, 1470, 10.1172/JCI28735 Cryer, 2007, Hypoglycemia, functional brain failure, and brain death, J Clin Invest, 117, 868, 10.1172/JCI31669 Cryer, 2008, The barrier of hypoglycemia in diabetes, Diabetes, 57, 3169, 10.2337/db08-1084 Cryer, 2009 Cryer, 2009, Preventing hypoglycaemia: what is the appropriate glucose alert value?, Diabetologia, 52, 35, 10.1007/s00125-008-1205-7 Cryer, 2011, Elimination of hypoglycemia from the lives of people affected by diabetes, Diabetes, 60, 24, 10.2337/db10-1359 Currie, 2010, Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study, Lancet, 375, 481, 10.1016/S0140-6736(09)61969-3 Dagogo-Jack, 1993, Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia, J Clin Invest, 91, 819, 10.1172/JCI116302 Dagogo-Jack, 1994, Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM, Diabetes, 43, 1426, 10.2337/diab.43.12.1426 de Galan, 2004, Plasma metanephrine levels are decreased in type 1 diabetic patients with a severely impaired epinephrine response to hypoglycemia, indicating reduced adrenomedullary stores of epinephrine, J Clin Endocrinol Metab, 89, 2057, 10.1210/jc.2003-031289 DeRosa, 2004, Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation, Am J Physiol Endocrinol Metab, 287, E32, 10.1152/ajpendo.00539.2003 Diabetes Control and Complications Trial Research Group (DCCT), 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group, 2005, Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes, N Engl J Med, 353, 2643, 10.1056/NEJMoa052187 Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC), 2007, Long-term effect of diabetes and its treatment on cognitive function, N Engl J Med, 356, 1842, 10.1056/NEJMoa066397 Diem, 1990, Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts, J Clin Invest, 86, 2008, 10.1172/JCI114936 Donnelly, 2005, Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study, Diabet Med, 22, 749, 10.1111/j.1464-5491.2005.01501.x Fanelli, 1993, Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM, Diabetes, 42, 1683, 10.2337/diab.42.11.1683 Fanelli, 1994, Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM, Diabetologia, 37, 1265, 10.1007/BF00399801 Feltbower, 2008, Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes: results from the Yorkshire Register of Diabetes in Children and Young Adults, Diabetes Care, 31, 922, 10.2337/dc07-2029 Ferner, 1988, Sulphonylureas and hypoglycaemia, Br Med J (Clin Res Ed), 296, 949, 10.1136/bmj.296.6627.949 Ferrannini, 2010, Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial, Diabetes Care, 33, 2217, 10.2337/dc10-0612 Geddes, 2008, Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes, Diabet Med, 25, 501, 10.1111/j.1464-5491.2008.02413.x Gerich, 1989, Oral hypoglycemic agents, N Engl J Med, 321, 1231, 10.1056/NEJM198911023211805 Gerich, 1974, Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas, J Clin Invest, 54, 833, 10.1172/JCI107823 Gill, 2009, Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes – the “dead in bed” syndrome revisited, Diabetologia, 52, 42, 10.1007/s00125-008-1177-7 Goldstein, 2008, Adrenomedullary, adrenocortical, and sympathoneural responses to stressors: a meta-analysis, Endocr Regul, 42, 111 Gosmanov, 2005, Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans, Diabetes Care, 28, 1124, 10.2337/diacare.28.5.1124 Heller, 1991, Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans, Diabetes, 40, 223, 10.2337/diab.40.2.223 Hepburn, 1993, Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin, Diabet Med, 10, 231, 10.1111/j.1464-5491.1993.tb00050.x Holman, 2008, 10-year follow-up of intensive glucose control in type 2 diabetes, N Engl J Med, 359, 1577, 10.1056/NEJMoa0806470 Holstein, 2003, Risk of hypoglycaemia with oral antidiabetic agents in patients with type 2 diabetes, Exp Clin Endocrinol Diabetes, 111, 405, 10.1055/s-2003-44287 International Diabetes Federation, 2009 Israelian, 2005, Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 diabetes, Diabetes Care, 28, 2691, 10.2337/diacare.28.11.2691 Jaferi, 2006, Corticosterone can act at the posterior paraventricular thalamus to inhibit hypothalamic–pituitary–adrenal activity in animals that habituate to repeated stress, Endocrinology, 147, 4917, 10.1210/en.2005-1393 Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, 2008, Continuous glucose monitoring and intensive treatment of type 1 diabetes, N Engl J Med, 359, 1464, 10.1056/NEJMoa0805017 Lachin, 2008, Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial – revisited, Diabetes, 57, 995, 10.2337/db07-1618 Lee, 2003, Effects of adrenaline and potassium on QTC interval and QT dispersion in man, Eur J Clin Invest, 33, 93, 10.1046/j.1365-2362.2003.01123.x Lee, 2005, Effect of atenolol on QTc interval lengthening during hypoglycaemia in type 1 diabetes, Diabetologia, 48, 1269, 10.1007/s00125-005-1796-1 MacDonald, 2007, A KATP channel-dependent pathway within alpha cells regulates glucagon release from both rodent and human islets of Langerhans, PLoS Biol, 5, e143, 10.1371/journal.pbio.0050143 McCrimmon, 2010, Hypoglycemia in type 1 diabetes, Diabetes, 59, 2333, 10.2337/db10-0103 Murphy, 2004, Prolonged cardiac repolarisation during spontaneous nocturnal hypoglycaemia in children and adolescents with type 1 diabetes, Diabetologia, 47, 1940, 10.1007/s00125-004-1552-y NICE-SUGAR Study Investigators, 2009, Intensive versus conventional glucose control in critically ill patients, N Engl J Med, 360, 1283, 10.1056/NEJMoa0810625 Nordin, 2010, The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence, Diabetologia, 53, 1552, 10.1007/s00125-010-1752-6 Paramore, 1998, Forearm norepinephrine spillover during standing, hyperinsulinemia, and hypoglycemia, Am J Physiol, 275, E872 Paranjape, 2010, Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo, Diabetes, 59, 1521, 10.2337/db10-0014 Pedersen-Bjergaard, 2003, Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes, Diabetes Metab Res Rev, 19, 232, 10.1002/dmrr.377 Phung, 2010, Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes, JAMA, 303, 1410, 10.1001/jama.2010.405 Pogach, 2010, Balancing hypoglycemia and glycemic control: a public health approach for insulin safety, JAMA, 303, 2076, 10.1001/jama.2010.655 Puente, 2010, Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia, Diabetes, 59, 1055, 10.2337/db09-1495 Raju, 2005, Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans, Diabetes, 54, 757, 10.2337/diabetes.54.3.757 Reichard, 1994, Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study, Diabetes, 43, 313, 10.2337/diab.43.2.313 Robinson, 2003, Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia, Diabetes, 52, 1469, 10.2337/diabetes.52.6.1469 Robinson, 2004, Changes in cardiac repolarization during clinical episodes of nocturnal hypoglycaemia in adults with type 1 diabetes, Diabetologia, 47, 312, 10.1007/s00125-003-1292-4 Ryder, 1990, Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy, BMJ, 301, 783, 10.1136/bmj.301.6755.783 Schernthaner, 2010, Diabetes and cardiovascular disease: is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR, Wien Med Wochenschr, 160, 8, 10.1007/s10354-010-0748-7 Schopman, 2010, Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes, Diabetes Res Clin Pract, 87, 64, 10.1016/j.diabres.2009.10.013 Segel, 2002, Hypoglycemia-associated autonomic failure in advanced type 2 diabetes, Diabetes, 51, 724, 10.2337/diabetes.51.3.724 Sherck, 2001, Pancreatic response to mild non-insulin-induced hypoglycemia does not involve extrinsic neural input, Diabetes, 50, 2487, 10.2337/diabetes.50.11.2487 Sjöbom, 1989, The prevalence of impaired glucose counter-regulation during an insulin-infusion test in insulin-treated diabetic patients prone to severe hypoglycaemia, Diabetologia, 32, 818, 10.1007/BF00264914 Skrivarhaug, 2006, Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway, Diabetologia, 49, 298, 10.1007/s00125-005-0082-6 Skyler, 2009, Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials, Diabetes Care, 32, 187, 10.2337/dc08-9026 Taborsky, 2009, Loss of islet sympathetic nerves and impairment of glucagon secretion in the NOD mouse: relationship to invasive insulitis, Diabetologia, 52, 2602, 10.1007/s00125-009-1494-5 Tanenberg, 2010, Confirmation of hypoglycemia in the “dead-in-bed” syndrome, as captured by a retrospective continuous glucose monitoring system, Endocr Pract, 16, 244, 10.4158/EP09260.CR Tesfaye, 2010, Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments, Diabetes Care, 33, 2285, 10.2337/dc10-1303 Teves, 2004, Activation of human medial prefrontal cortex during autonomic responses to hypoglycemia, Proc Natl Acad Sci U S A, 101, 6217, 10.1073/pnas.0307048101 Towler, 1993, Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms, Diabetes, 42, 1791, 10.2337/diab.42.12.1791 UK Hypoglycaemia Study Group, 2007, Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration, Diabetologia, 50, 1140, 10.1007/s00125-007-0599-y UK Prospective Diabetes Study (UKPDS) Group, 1998, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), Lancet, 352, 854, 10.1016/S0140-6736(98)07037-8 UK Prospective Diabetes Study (UKPDS) Group, 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 UK Prospective Diabetes Study (UKPDS) Group, 1998, United Kingdom Prospective Diabetes Study 24: A 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy, Ann Intern Med, 128, 165, 10.7326/0003-4819-128-3-199802010-00001 White, 1983, Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy, N Engl J Med, 308, 485, 10.1056/NEJM198303033080903 Yudkin, 2010, Intensified glucose lowering in type 2 diabetes: time for a reappraisal, Diabetologia, 53, 2079, 10.1007/s00125-010-1864-z